ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,739, issued on Jan. 27, was assigned to Decibel Therapeutics Inc. (Boston).

"AAV1 vectors and uses thereof for treatment of otic indications" was invented by Joseph Burns (Newton, Mass.), Kathryn Ellis (Arlington, Mass.), Matthew Nguyen (Boston), Adam Palermo (Somerville, Mass.), Gabriela Pregernig (Boston), Fuxin Shi (Winchester, Mass.) and Jonathon Whitton (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides AAV1 vectors that can be used to transduce multiple inner ear cell types and their use for treatment of hearing loss, deafness, tinnitus, and vestibular dysfunction."

The patent was filed on Oct. 11, 2019, u...